CVS Caremark receives PBM, DTM accreditation from URAC
WOONSOCKET, R.I. — CVS Caremark announced on Thursday that it has been awarded pharmacy benefit management and drug therapy management accreditation from URAC, a healthcare accrediting organization that establishes quality standards for the healthcare industry. CVS Caremark previously had received accreditation for PBM and DTM from URAC in 2007.
"CVS Caremark is pleased to receive these accreditations," stated Per Lofberg, head of CVS Caremark’s PBM business. "This provides further validation of the company’s ongoing focus and commitment to patient care, outstanding customer service and overall quality."
URAC offers the only third-party, voluntary accreditation program of this scope for the PBM and prescription services industry. All standards were developed by URAC’s Pharmacy Advisory Committee, which includes stakeholders, employers, consumers, pharmacy consultants, health plans, retail pharmacy, PBM organizations, pharmacy professional organizations, labor and large public purchasing groups.
"By applying for and receiving URAC accreditation, CVS Caremark has demonstrated a commitment to quality health care," added Alan Spielman, URAC president and CEO. "Quality health care is crucial to our nation’s welfare, and it is important to have organizations that are willing to measure themselves against national standards and undergo rigorous evaluation by an independent accrediting body."
Rite Aid’s November, Q3 same-store sales drop
CAMP HILL, Pa. — Rite Aid on Thursday posted sales of $6.2 billion, down 2.3%, for its third quarter ended Nov. 27. Same-store sales for the period declined 1.3%, representing flat front-end sales and a pharmacy comparable sales decline of 1.9%.
For the five-week period ended Nov. 27, which includes Black Friday sales, front-end sales were up 1.3% while pharmacy same-store sales, which included an approximate 248 basis points negative impact from new generic introductions, declined 2.5%. Overall monthly comps fell 1.3%.
Over the course of the quarter, prescription revenue represented 68.3% of total drug store sales, and third-party prescription revenue was 96.2% of pharmacy sales.
BioPlus Specialty Pharmacy: Services help boost adherence among patients
ALTAMONTE SPRINGS, Fla. — Nearly all surveyed patients using BioPlus Specialty Pharmacy’s services over the last six years adhered to their therapies, according to recent statistics.
Quarterly data collected between 2004 and 2010 found that of 17,000 patients analyzed, compliance at the time of discharge was 92%.
“This retrospective data demonstrates to the payers, prescribers, pharma and patients that we are measurably improving outcomes as we daily manage specialty therapies,” BioPlus CEO Stephen Vogt said. “This is our mission. We will continue to be the innovators of valued solutions as we enhance our pharmaceutical management programs.”
The company said its staff was trained to identify signs of adherence and compliance problems, and to intervene when necessary in the form of consultations with doctors of pharmacy who attempt to discern and help resolve issues that lead to adherence problems.
“This data is part of our quality assessment results that we review quarterly,” BioPlus director of pharmacy services Nick Maroulis said. “By asking the question, ‘How can we improve compliance?,’ our entire clinical team is comfortable that we have found the answers, and the data over the years demonstrates that.”